Eaton Vance Management 10x Genomics, Inc. Transaction History

Eaton Vance Management

$67.5 Billion
Q3 2022

A detailed history of Eaton Vance Management transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Eaton Vance Management holds 501,952 shares of TXG stock, worth $7.94 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

501,952

Previous 744,274 32.56%

Holding current value

$7.94 Million

Previous $33.7 Million 57.55%

% of portfolio

0.02%

Previous 0.05%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$28.48 - $52.59 $6.9 Million - $12.7 Million	-242,322 Reduced 32.56%	501,952 $14.3 Million
Q2 2022 Aug 15, 2022	BUY	$36.95 - $82.41 $2.27 Million - $5.06 Million	61,411 Added 8.99%	744,274 $33.7 Million
Q1 2022 May 16, 2022	SELL	$55.7 - $145.79 $1.82 Million - $4.77 Million	-32,718 Reduced 4.57%	682,863 $51.9 Million
Q4 2021 Feb 14, 2022	SELL	$135.05 - $182.59 $2.39 Million - $3.23 Million	-17,666 Reduced 2.41%	715,581 $107 Million
Q3 2021 Nov 15, 2021	BUY	$145.58 - $192.14 $1.25 Million - $1.65 Million	8,578 Added 1.18%	733,247 $107 Million
Q2 2021 Aug 16, 2021	BUY	$134.22 - $202.37 $31.2 Million - $47 Million	232,488 Added 47.24%	724,669 $142 Million
Q1 2021 May 17, 2021	BUY	$140.25 - $196.86 $31.1 Million - $43.6 Million	221,396 Added 81.76%	492,181 $89.1 Million
Q4 2020 Feb 12, 2021	SELL	$126.47 - $163.7 $2.89 Million - $3.74 Million	-22,830 Reduced 7.78%	270,785 $38.3 Million
Q3 2020 Nov 13, 2020	BUY	$87.44 - $125.0 $2.4 Million - $3.43 Million	27,412 Added 10.3%	293,615 $36.6 Million
Q2 2020 Nov 20, 2020	BUY	$58.39 - $89.31 $9,984 - $15,272	171 Added 0.06%	266,203 $23.8 Million
Q2 2020 Aug 13, 2020	BUY	$58.39 - $89.31 $931,378 - $1.42 Million	15,951 Added 6.38%	266,032 $23.8 Million
Q1 2020 May 14, 2020	BUY	$51.57 - $106.62 $8.37 Million - $17.3 Million	162,308 Added 184.92%	250,081 $15.6 Million
Q4 2019 Feb 11, 2020	BUY	$46.07 - $79.54 $2.78 Million - $4.8 Million	60,333 Added 219.87%	87,773 $6.69 Million
Q3 2019 Nov 14, 2019	BUY	$49.99 - $62.0 $1.37 Million - $1.7 Million	27,440 New	27,440 $1.38 Million

Others Institutions Holding TXG

# of Institutions

291

Shares Held

94.7M

Call Options Held

263K

Put Options Held

85.1K

View Full List

About 10x Genomics, Inc.

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.5B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

More about TXG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

News

Stay updated on Eaton Vance Management with notifications on news.

Account

Eaton Vance Management 10x Genomics, Inc. Transaction History